203 studies found for:    lupus | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)
Condition: Lupus Nephritis
Intervention: Procedure: Renal Biopsy
22 Recruiting Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Condition: Systemic Lupus Erythematosus, Lupus Nephritis
Interventions: Drug: Oral prednisolone;   Drug: Rituximab;   Drug: Mycophenolate mofetil;   Drug: Methyl prednisolone
23 Unknown  HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Behavioral: Education
24 Unknown  Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus.
Conditions: Systemic Lupus Erythematosus;   Sleep Disorders
Interventions: Procedure: Aerobic Exercise;   Other: Control Group
25 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
26 Recruiting A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: CC-220;   Drug: Placebo
27 Recruiting Study to Evaluate BIIB059 in CLE With or Without SLE
Conditions: Systemic Lupus Erythematosus (SLE);   Active Cutaneous Lupus Erythematosus (CLE)
Interventions: Drug: BIIB059;   Drug: Placebo
28 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
29 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus;   SLE
Interventions: Drug: Mycophenolate Mofetil;   Drug: Hydroxychloroquine or Chloroquine;   Drug: Prednisone
30 Recruiting Autologous Polyclonal Tregs for Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Intervention: Biological: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
31 Not yet recruiting Lupus Intervention for Fatigue Trial
Conditions: Fatigue;   Physical Activity;   Lupus Erythematosus, Systemic
Interventions: Behavioral: Experimental;   Other: Control
32 Recruiting Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Brentuximab vedotin;   Drug: Placebo
33 Recruiting A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE)
Interventions: Drug: Placebo;   Drug: Dapirolizumab pegol (DZP)
34 Unknown  Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: human umbilical cord derived MSC transplantation for SLE
35 Recruiting Low-dose UVA1 Radiation in Cutaneous Lupus Patients
Condition: Cutaneous Lupus Erythematosus
Intervention: Device: UVA1 radiation treatment
36 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
37 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
38 Recruiting A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: XmAb5871;   Biological: Placebo to match XmAb5871
39 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
40 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years